Revival of an old drug, declaration of independence for seniors, inmates doing more than time—these and other stories are covered in our monthly roundup.
For the first time, a study has shown comprehensive evidence for the effect of depression on decline in overall cognitive function. Plus, 2 more findings.
Negative symptoms identified from the Negative Symptom Assessment and the behaviors that might be observed in each of 5 domains.
Three new studies examine research on biomarkers to predict lifetime risk of Alzheimer disease; diet and brain tissue volume; and cognitive impairment in active older adults.
A rare but serious reaction to this treatment can have immunological consequences. As with all medications, however, the latest alert does not change how psychiatrists manage the risks.
The Department of Justice apprehended a perpetrator whose electronic stalking behaviors went to the extreme. This and other editors’ choices on stories you may have missed.
Handgrip is a simple proxy for physical strength and a clinically useful measure of muscular function. What about cognitive function in patients with schizophrenia? A large study looked into just that.
Hot off the press: Three new studies, including one that reports middle-age physically fit women are nearly 90% less likely to develop dementia decades later.
Relapse in MDD is associated with morphologic brain changes; stopping exercise may increase depressive symptoms; and inflammatory biomarkers may predict which treatment-resistant MDD patients benefit from ECT.
This report includes a study on patterns of prodromal psychiatric symptoms that may help identify young persons at increased risk of bipolar disorder; sibling bullying and risk of psychotic disorders; and a new smartphone app that tracks moods and predicts bipolar disorder episodes.